Skip to main content

Author: Customer Service

Lleida.net presents in Kazakhstan its digital certification solutions, and its CEO, Sisco Sapena, takes part in the fraud panel at CIS 2026 GCCM Almaty.

Lleida.net at CIS 2026 GCCM Almaty fraud prevention panelSisco Sapena, CEO of Lleida.net, takes part in the panel “Network APIs and Fraud Prevention: Strengthening Digital Trust Through Open Network Intelligence” at CIS 2026 GCCM Almaty, held in Almaty, Kazakhstan, on September 4, 2026.Almaty, KAZAKHSTAN, September 4, 2026.- Technology services company Lleida.net (BME:LLN, EPA:ALLLN) has presented its digital certification services in Kazakhstan for the first time, on the occasion of its participation in CIS 2026 GCCM Almaty, held from September 2 to 4 at the Royal Tulip Hotel in Almaty. Organized by Carrier Community (CC), CIS GCCM Almaty is holding its ninth annual meeting this year and is one of the leading gatherings for the wholesale telecommunications community. The event brings together more than 400 members...

Continue reading

Nanox Signs Distribution Agreement with Associated X-Ray Imaging to Expand Nanox.ARC Adoption Across New England

Expands Nanox’s growing U.S. distribution network with a leading New England-based medical imaging provider PETACH TIKVA, Israel — September 4 2026 — Nano-X Imaging Ltd. (“Nanox”, or the “Company”, NASDAQ: NNOX), a leader in innovative medical imaging technology, today announced that its U.S.-based subsidiary, Nanox Impact Inc., has entered into a distribution agreement with Associated X-Ray Imaging Corp., a New England-based provider of medical imaging equipment and services, specializing in X-ray, MRI, and CT systems, to support deployment of the Nanox.ARC across the region. Under the agreement, Associated X-Ray Imaging will market, distribute, and support the Nanox.ARC, an FDA-cleared, multisource 3D digital tomosynthesis system, leveraging its established regional presence and service infrastructure across New England. The collaboration...

Continue reading

Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care

Adds gildeuretinol (ALK-001), a differentiated Phase 3 oral investigational medicine designed to target the underlying biology of Stargardt’s disease, a potentially blinding disease with no FDA-approved therapy Strengthens Tarsus’ differentiated pipeline and leadership in eye care IRVINE, Calif., Sept. 04, 2026 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) today announced that it has completed its previously announced acquisition of Alkeus Pharmaceuticals, Inc., a privately held retinal disease-focused biotechnology company. With the completion of the acquisition, Tarsus adds worldwide rights to ALK-001, a new, investigational, late-stage molecular entity designed to reduce the accumulation of toxic dimers while preserving the normal visual cycle. Tarsus believes ALK-001 represents a potential blockbuster opportunity...

Continue reading

CUENTAS, INC. REPORTS SECOND QUARTER 2026 RESULTS AND ANNOUNCES 4,000+ ACTIVE MOBILITY CUSTOMERS.

Miami Beach, Florida, Sept. 04, 2026 (GLOBE NEWSWIRE) — Cuentas, Inc. (OTCQB: CUEN) (“Cuentas” or the “Company”), a cellular-focused technology company developing and expanding its mobile connectivity and digital services platform, today announced its financial results for the second quarter ended June 30, 2026, and announced it has over 4,000 active mobility customers. The Company’s second-quarter filing reflects continued progress in the transformation of Cuentas toward a mobility-centered operating model, including the development and commercialization of its mobile services platform through its majority-owned World Mobile LLC joint venture. Building a Scalable Cellular-Mobility Platform Cuentas holds a 51% membership interest in World Mobile LLC, its joint venture with World Mobile Group, and consolidates World Mobile LLC for...

Continue reading

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PRINCETON, N.J., Sept. 04, 2026 (GLOBE NEWSWIRE) — UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced the grants of inducement restricted stock units (“RSUs”) to 19 new employees in connection with their employment with UroGen. These new team members will support the ongoing commercialization of JELMYTO® (mitomycin) for pyelocalyceal solution and ZUSDURI™ (mitomycin) for intravesical solution, UroGen’s only approved products, and the continued development of UroGen’s pipeline. Up to 117,100 ordinary shares of UroGen are issuable upon the vesting and settlement of the RSUs. The RSUs will vest equally over three years, with one-third of the underlying shares vesting each year on the anniversary of...

Continue reading

Hurco Reports Profit in Third Quarter Results for Fiscal Year 2026

INDIANAPOLIS, Sept. 04, 2026 (GLOBE NEWSWIRE) — Hurco Companies, Inc. (Nasdaq: HURC) today reported results for the third fiscal quarter ended July 31, 2026. Hurco recorded net income of $2,314,000, or $0.35 per diluted share, for the third quarter of fiscal year 2026, compared to a net loss of $3,693,000, or $(0.58) per diluted share, for the corresponding period in fiscal year 2025. For the first nine months of fiscal year 2026, Hurco reported a net loss of $3,526,000, or $(0.55) per diluted share, compared to a net loss of $12,076,000, or $(1.87) per diluted share, for the corresponding period in fiscal year 2025. Sales and service fees for the third quarter of fiscal year 2026 were $47,289,000, an increase of $1,483,000, or 3%, compared to the corresponding prior year period, and included an unfavorable currency impact of $20,000,...

Continue reading

Edible Garden Launches First-to-Market USDA Organic CEA-Grown Basil at Wakefern/ShopRite

Exclusive Program Expands ShopRite Distribution Ahead of Labor Day Utilizes Wakefern Backhaul Network to Enhance Supply-Chain Efficiency, Reduce Food Miles and Support Edible Garden’s Zero-Waste Inspired® Mission BELVIDERE, NJ, Sept. 04, 2026 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), organic and sustainable produce, and developer of the Zero-Waste Inspired® mission and Farm-to-Formula® platform today announced that it has begun shipping what the Company believes to be the CEA industry’s first verified USDA Organic basil to Wakefern Food Corp. for distribution to participating ShopRite stores as part of an exclusive program. The expanded distribution comes ahead of Labor Day weekend, a period of increased demand...

Continue reading

Statement: EdgeMode confirms that the current review process with BlackBerry AIF and BLACK AI Group will be extended for up to six months

FORT LAUDERDALE, Fla., Sept. 04, 2026 (GLOBE NEWSWIRE) — EdgeMode, Inc. (OTC: EDGM) today announces that, by mutual agreement with BlackBerry AIF and BLACK AI Group, the current review process between the parties will be extended for an additional period of up to six months. During this period, BLACK AI Group will continue to advance independently with the development of its AI infrastructure platform, including its large-scale data center projects, strategic partnerships, and financing strategy. The parties remain aligned around the opportunities within the AI infrastructure sector and will use this additional period to complete their strategic, corporate, and commercial review, while EdgeMode undertakes the internal corporate, financial, and strategic work required to support any potential future transaction. Potential structures...

Continue reading

SUTNTIB AB Tewox publishes its NAV for August 2026

Vilnius, Lithuania, Sept. 04, 2026 (GLOBE NEWSWIRE) — As at the end of August 2026, the net asset value (NAV) of SUTNTIB AB Tewox decreased to EUR 45,190,557, compared to the previously determined NAV of EUR 45,671,734 at the end of July 2026. The share price decreased to EUR 1.0795, from EUR 1.0910 at the end of July 2026. The pro-forma internal rate of return (IRR) decreased to 3.51%, compared to previously announced IRR of 3.81% at the end of July 2026. Contact person for further information: Paulius NevinskasManager of the Investment Companypaulius.nevinskas@lordslb.lthttps://lordslb.lt/tewox_bonds/

Continue reading

OSB GROUP PLC – Holding(s) in Company

TR-1: Standard form for notification of major holdings 1.  Issuer Details ISIN GB00BLDRH360 Issuer Name OSB GROUP PLC UK or Non-UK Issuer UK 2.  Reason for Notification An acquisition or disposal of voting rights 3.  Details of person subject to the notification obligation Name Lorentzweiler Adjacent Partners S.C.Sp. City of registered office (if applicable) Howald Country of registered office (if applicable) Luxembourg 4.  Details of the shareholder Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above City of registered office (if applicable) Country of registered office (if applicable) 5.  Date on which the threshold was crossed or reached 01-Sep-2026 6.  Date on which Issuer notified 03-Sep-2026 7.  Total positions of person(s) subject to the notification...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.